This webinar offered “how-tos” on agency consent for psychotropic medications for children in foster care, highlighting three state models that rely on medical expertise to inform consent decisions.
Presenters from New Jersey, Connecticut and Illinois described their respective state programs, including information about the medical expertise embedded in the consent process; the agency staff authorized to provide consent; program funding; and program costs, among other issues. The presenters also provided insights regarding the design and implementation of their models, as well as lessons to guide other states in managing their consent processes.
- Mary Beirne, Chief Child and Adolescent Psychiatrist, New Jersey Department of Children and Families
- Debra Lancaster, Director, Office of Child and Family Health for New Jersey Department of Children and Families
- Lesley Siegel, Chief of Psychiatry, Connecticut Department of Children and Families
- Mike Naylor, Director, Clinical Services in Psychopharmacology, University of Illinois at Chicago